$ALNY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALNYLAM PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALNYLAM PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ALNYLAM PHARMACEUTICALS, INC. for free.
Page: < prev 1 2 3 4 5 6 ... 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | PYOTT DAVID E I | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILLIP A | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | SCHULMAN AMY W | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | Reitan Colleen F | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jul 06 2020 | ALNY | ALNYLAM PHARMACEUT ... | PYOTT DAVID E I | Director | Option Exercise | A | 148.77 | 4,581 | 681,515 | 4,581 | |
Jun 24 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 42.22 | 970 | 40,953 | 4,309 | |
Jun 24 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 152.97 | 195 | 29,829 | 14,119 | 14.3 K to 14.1 K (-1.36 %) |
Jun 24 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 152.22 | 334 | 50,841 | 14,314 | 14.6 K to 14.3 K (-2.28 %) |
Jun 24 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 150.34 | 180 | 27,061 | 14,648 | 14.8 K to 14.6 K (-1.21 %) |
Jun 24 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 149.09 | 83 | 12,374 | 14,828 | 14.9 K to 14.8 K (-0.56 %) |
Jun 24 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 148.48 | 178 | 26,429 | 14,911 | 15.1 K to 14.9 K (-1.18 %) |
Jun 24 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 42.22 | 970 | 40,953 | 15,089 | 14.1 K to 15.1 K (+6.87 %) |
May 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 9.14 | 34,765 | 317,752 | 69,530 | |
May 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 144.33 | 5,013 | 723,526 | 197,589 | 202.6 K to 197.6 K (-2.47 %) |
May 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 143.46 | 16,315 | 2,340,550 | 202,602 | 218.9 K to 202.6 K (-7.45 %) |
May 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 142.51 | 13,437 | 1,914,907 | 218,917 | 232.4 K to 218.9 K (-5.78 %) |
May 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 9.14 | 34,765 | 317,752 | 232,354 | 197.6 K to 232.4 K (+17.59 %) |
May 07 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | M | 77.10 | 50,000 | 3,855,000 | 75,000 | |
May 07 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | M | 42.22 | 1,561 | 65,905 | 14,064 | |
May 07 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | M | 42.22 | 6,250 | 263,875 | 650 | |
May 07 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Sell | S | 150.00 | 50,000 | 7,500,000 | 4,820 | 54.8 K to 4.8 K (-91.21 %) |
May 07 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Buy | M | 77.10 | 50,000 | 3,855,000 | 54,820 | 4.8 K to 54.8 K (+1,037.34 %) |
May 07 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Sell | S | 140.00 | 7,811 | 1,093,540 | 4,820 | 12.6 K to 4.8 K (-61.84 %) |
May 07 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Buy | M | 42.22 | 1,561 | 65,905 | 12,631 | 11.1 K to 12.6 K (+14.10 %) |
May 07 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Buy | M | 42.22 | 6,250 | 263,875 | 11,070 | 4.8 K to 11.1 K (+129.67 %) |
Apr 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | M | 77.40 | 10,000 | 774,000 | 42,000 | |
Apr 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 139.00 | 10,000 | 1,390,000 | 14,492 | 24.5 K to 14.5 K (-40.83 %) |
Apr 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | M | 77.40 | 10,000 | 774,000 | 24,492 | 14.5 K to 24.5 K (+69.00 %) |
Apr 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 42.22 | 971 | 40,996 | 5,279 | |
Apr 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 42.22 | 21,000 | 886,620 | 0 | |
Apr 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 140.00 | 21,971 | 3,075,940 | 14,119 | 36.1 K to 14.1 K (-60.88 %) |
Apr 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 42.22 | 971 | 40,996 | 36,090 | 35.1 K to 36.1 K (+2.76 %) |
Apr 22 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 42.22 | 21,000 | 886,620 | 35,119 | 14.1 K to 35.1 K (+148.74 %) |
Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Payment of Exercise | F | 106.65 | 64 | 6,826 | 62,236 | 62.3 K to 62.2 K (-0.10 %) |
Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Payment of Exercise | F | 104.75 | 1,599 | 167,495 | 62,300 | 63.9 K to 62.3 K (-2.50 %) |
Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Grant | A | 0.00 | 5,417 | 0 | 63,899 | 58.5 K to 63.9 K (+9.26 %) |
Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Payment of Exercise | F | 107.47 | 98 | 10,532 | 4,820 | 4.9 K to 4.8 K (-1.99 %) |
Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Payment of Exercise | F | 104.75 | 2,415 | 252,971 | 4,918 | 7.3 K to 4.9 K (-32.93 %) |
Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Grant | A | 0.00 | 5,417 | 0 | 7,333 | 1.9 K to 7.3 K (+282.72 %) |
Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Payment of Exercise | F | 106.27 | 256 | 27,205 | 197,589 | 197.8 K to 197.6 K (-0.13 %) |
Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Payment of Exercise | F | 104.75 | 6,315 | 661,496 | 197,845 | 204.2 K to 197.8 K (-3.09 %) |
Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Grant | A | 0.00 | 14,167 | 0 | 204,160 | 190 K to 204.2 K (+7.46 %) |
Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 106.52 | 98 | 10,439 | 14,119 | 14.2 K to 14.1 K (-0.69 %) |
Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Payment of Exercise | F | 104.75 | 2,415 | 252,971 | 14,217 | 16.6 K to 14.2 K (-14.52 %) |
Apr 09 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Grant | A | 0.00 | 5,417 | 0 | 16,632 | 11.2 K to 16.6 K (+48.30 %) |
Mar 04 2020 | ALNY | ALNYLAM PHARMACEUT ... | BRANDICOURT OLIVIER | Director | Option Exercise | A | 114.78 | 8,612 | 988,485 | 8,612 | |
Feb 28 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | A | 118.05 | 24,554 | 2,898,600 | 24,554 | |
Feb 28 2020 | ALNY | ALNYLAM PHARMACEUT ... | Poulton Jeffrey V. | Chief Financial Off ... | Option Exercise | A | 118.05 | 24,554 | 2,898,600 | 24,554 | |
Feb 28 2020 | ALNY | ALNYLAM PHARMACEUT ... | Poulton Jeffrey V. | Chief Financial Off ... | Buy | J | 0.00 | 19 | 0 | 19 | 0 to 19 |
Feb 28 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 118.05 | 27,623 | 3,260,895 | 27,623 | |
Feb 28 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 118.05 | 88,240 | 10,416,732 | 88,240 | |
Feb 28 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 118.05 | 29,925 | 3,532,646 | 29,925 | |
Feb 28 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | A | 118.05 | 27,623 | 3,260,895 | 27,623 | |
Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 9.14 | 34,765 | 317,752 | 104,295 | |
Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 133.42 | 502 | 66,977 | 189,993 | 190.5 K to 190 K (-0.26 %) |
Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 132.81 | 18,065 | 2,399,213 | 190,495 | 208.6 K to 190.5 K (-8.66 %) |
Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 131.61 | 6,887 | 906,398 | 208,560 | 215.4 K to 208.6 K (-3.20 %) |
Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 131.07 | 5,053 | 662,297 | 215,447 | 220.5 K to 215.4 K (-2.29 %) |
Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 129.33 | 1,586 | 205,117 | 220,500 | 222.1 K to 220.5 K (-0.71 %) |
Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 128.62 | 2,672 | 343,673 | 222,086 | 224.8 K to 222.1 K (-1.19 %) |
Feb 21 2020 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 9.14 | 34,765 | 317,752 | 224,758 | 190 K to 224.8 K (+18.30 %) |
Feb 12 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | M | 77.40 | 10,000 | 774,000 | 52,000 | |
Feb 12 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 129.00 | 10,000 | 1,290,000 | 12,258 | 22.3 K to 12.3 K (-44.93 %) |
Feb 12 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | M | 77.40 | 10,000 | 774,000 | 22,258 | 12.3 K to 22.3 K (+81.58 %) |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | M | 14.67 | 30,000 | 440,100 | 0 | |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Sell | S | 130.00 | 30,000 | 3,900,000 | 1,000 | 31 K to 1,000 (-96.77 %) |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Buy | M | 14.67 | 30,000 | 440,100 | 31,000 | 1,000 to 31 K (+3,000.00 %) |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 42.22 | 18,750 | 791,625 | 6,250 | |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | M | 42.22 | 4,000 | 168,880 | 21,000 | |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Sell | S | 125.00 | 23,708 | 2,963,500 | 11,215 | 34.9 K to 11.2 K (-67.89 %) |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 42.22 | 4,000 | 168,880 | 34,923 | 30.9 K to 34.9 K (+12.94 %) |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | M | 42.22 | 18,750 | 791,625 | 30,923 | 12.2 K to 30.9 K (+154.03 %) |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | M | 42.22 | 5,600 | 236,432 | 6,900 | |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | M | 42.22 | 6,250 | 263,875 | 12,500 | |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Sell | S | 130.00 | 9,892 | 1,285,960 | 1,916 | 11.8 K to 1.9 K (-83.77 %) |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Buy | M | 42.22 | 5,600 | 236,432 | 11,808 | 6.2 K to 11.8 K (+90.21 %) |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Sell | S | 123.90 | 6,250 | 774,375 | 6,208 | 12.5 K to 6.2 K (-50.17 %) |
Feb 11 2020 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Buy | M | 42.22 | 6,250 | 263,875 | 12,458 | 6.2 K to 12.5 K (+100.68 %) |
Jan 29 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | M | 77.40 | 3,663 | 283,516 | 68,337 | |
Jan 29 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | M | 42.22 | 9,374 | 395,770 | 6,252 | |
Jan 29 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | M | 42.22 | 25,000 | 1,055,500 | 0 | |
Jan 29 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 120.21 | 190 | 22,840 | 8,595 | 8.8 K to 8.6 K (-2.16 %) |
Jan 29 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 119.53 | 6,667 | 796,907 | 8,785 | 15.5 K to 8.8 K (-43.15 %) |
Jan 29 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 118.61 | 13,084 | 1,551,893 | 15,452 | 28.5 K to 15.5 K (-45.85 %) |
Jan 29 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 117.67 | 4,100 | 482,447 | 28,536 | 32.6 K to 28.5 K (-12.56 %) |
Jan 29 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 116.43 | 13,631 | 1,587,057 | 32,636 | 46.3 K to 32.6 K (-29.46 %) |
Jan 29 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Sell | S | 115.55 | 3,365 | 388,826 | 46,267 | 49.6 K to 46.3 K (-6.78 %) |
Jan 29 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | M | 42.22 | 25,000 | 1,055,500 | 49,632 | 24.6 K to 49.6 K (+101.49 %) |
Jan 29 2020 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | M | 42.22 | 9,374 | 395,770 | 24,632 | 15.3 K to 24.6 K (+61.44 %) |
Dec 26 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 119.13 | 8,333 | 992,710 | 16,666 | |
Dec 26 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 119.13 | 17,498 | 2,084,537 | 34,996 | |
Dec 26 2019 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | A | 119.13 | 4,583 | 545,973 | 9,166 | |
Dec 26 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | A | 119.13 | 8,333 | 992,710 | 16,666 | |
Dec 26 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 119.13 | 9,999 | 1,191,181 | 19,998 | |
Dec 13 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Payment of Exercise | F | 120.61 | 3,208 | 386,917 | 6,208 | 9.4 K to 6.2 K (-34.07 %) |
Dec 13 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Grant | A | 0.00 | 7,500 | 0 | 9,416 | 1.9 K to 9.4 K (+391.44 %) |
Nov 26 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 119.13 | 9,999 | 1,191,181 | 9,999 | |
Nov 26 2019 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | A | 119.13 | 4,583 | 545,973 | 4,583 | |
Nov 26 2019 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | J | 0.00 | 10 | 0 | 434 | 424 to 434 (+2.36 %) |
Nov 26 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | A | 119.13 | 8,333 | 992,710 | 8,333 | |
Nov 26 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 119.13 | 17,498 | 2,084,537 | 17,498 | |
Nov 26 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 119.13 | 8,333 | 992,710 | 8,333 | |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | M | 30.09 | 15,000 | 451,350 | 0 | |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | M | 9.30 | 15,000 | 139,500 | 0 | |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | M | 11.33 | 15,000 | 169,950 | 0 | |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Option Exercise | M | 9.14 | 30,000 | 274,200 | 0 | |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Sell | S | 100.00 | 75,000 | 7,500,000 | 0 | 75 K to 0 (-100.00 %) |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Buy | M | 30.09 | 15,000 | 451,350 | 75,000 | 60 K to 75 K (+25.00 %) |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Buy | M | 11.33 | 15,000 | 169,950 | 60,000 | 45 K to 60 K (+33.33 %) |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Buy | M | 9.30 | 15,000 | 139,500 | 45,000 | 30 K to 45 K (+50.00 %) |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Fanucci Marsha | Director | Buy | M | 9.14 | 30,000 | 274,200 | 30,000 | 0 to 30 K |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | M | 42.22 | 2,154 | 90,942 | 15,625 | |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | M | 42.22 | 6,250 | 263,875 | 18,750 | |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Sell | S | 105.00 | 8,404 | 882,420 | 1,916 | 10.3 K to 1.9 K (-81.43 %) |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Buy | M | 42.22 | 6,250 | 263,875 | 10,320 | 4.1 K to 10.3 K (+153.56 %) |
Nov 22 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Buy | M | 42.22 | 2,154 | 90,942 | 4,070 | 1.9 K to 4.1 K (+112.42 %) |
Nov 20 2019 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILLIP A | Director | Option Exercise | M | 16.43 | 15,000 | 246,450 | 0 | |
Nov 20 2019 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILLIP A | Director | Sell | S | 92.66 | 810 | 75,055 | 235,633 | 236.4 K to 235.6 K (-0.34 %) |
Nov 20 2019 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILLIP A | Director | Sell | S | 91.97 | 8,631 | 793,793 | 236,443 | 245.1 K to 236.4 K (-3.52 %) |
Nov 20 2019 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILLIP A | Director | Sell | S | 91.17 | 5,559 | 506,814 | 245,074 | 250.6 K to 245.1 K (-2.22 %) |
Nov 20 2019 | ALNY | ALNYLAM PHARMACEUT ... | SHARP PHILLIP A | Director | Buy | M | 16.43 | 15,000 | 246,450 | 250,633 | 235.6 K to 250.6 K (+6.37 %) |
Oct 24 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | M | 16.43 | 58,913 | 967,941 | 0 | |
Oct 24 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | J | 0.00 | 5,544 | 0 | 3,486 | 9 K to 3.5 K (-61.40 %) |
Oct 24 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | J | 0.00 | 5,544 | 0 | 58,482 | 52.9 K to 58.5 K (+10.47 %) |
Oct 24 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Sell | S | 89.99 | 58,913 | 5,301,581 | 52,938 | 111.9 K to 52.9 K (-52.67 %) |
Oct 24 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | M | 16.43 | 58,913 | 967,941 | 111,851 | 52.9 K to 111.9 K (+111.29 %) |
Oct 16 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | M | 16.43 | 49,456 | 812,562 | 0 | |
Oct 16 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 80.31 | 1,870 | 150,180 | 189,993 | 191.9 K to 190 K (-0.97 %) |
Oct 16 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 79.80 | 26,754 | 2,134,969 | 191,863 | 218.6 K to 191.9 K (-12.24 %) |
Oct 16 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Sell | S | 78.92 | 20,832 | 1,644,061 | 218,617 | 239.4 K to 218.6 K (-8.70 %) |
Oct 16 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | M | 16.43 | 49,456 | 812,562 | 239,449 | 190 K to 239.4 K (+26.03 %) |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Option Exercise | A | 42.22 | 6,250 | 263,875 | 25,000 | |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greenstreet Yvonne | Chief Operating Off ... | Buy | J | 0.00 | 50 | 0 | 407 | 357 to 407 (+14.01 %) |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | A | 42.22 | 6,250 | 263,875 | 25,000 | |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Option Exercise | A | 88.95 | 3,500 | 311,325 | 14,000 | |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | KEATING LAURIE | EVP, Chief Legal Of ... | Buy | J | 0.00 | 49 | 0 | 424 | 375 to 424 (+13.07 %) |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 42.22 | 6,250 | 263,875 | 25,000 | |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Option Exercise | A | 88.95 | 7,500 | 667,125 | 30,000 | |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Vaishnaw Akshay | President, R&D | Buy | J | 0.00 | 48 | 0 | 515 | 467 to 515 (+10.28 %) |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 42.22 | 6,250 | 263,875 | 25,000 | |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Option Exercise | A | 88.95 | 10,000 | 889,500 | 40,000 | |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | Greene Barry E | President | Buy | J | 0.00 | 46 | 0 | 3,003 | 3 K to 3 K (+1.56 %) |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 42.22 | 6,250 | 263,875 | 25,000 | |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Option Exercise | A | 88.95 | 16,250 | 1,445,438 | 65,000 | |
Aug 07 2019 | ALNY | ALNYLAM PHARMACEUT ... | MARAGANORE JOHN | Chief Executive Off ... | Buy | J | 0.00 | 34 | 0 | 3,133 | 3.1 K to 3.1 K (+1.10 %) |
Jul 02 2019 | ALNY | ALNYLAM PHARMACEUT ... | SCHIMMEL PAUL | Director | Option Exercise | A | 72.01 | 9,000 | 648,090 | 9,000 | |
Jul 02 2019 | ALNY | ALNYLAM PHARMACEUT ... | Reitan Colleen F | Director | Option Exercise | A | 72.01 | 9,000 | 648,090 | 9,000 | |
Jul 02 2019 | ALNY | ALNYLAM PHARMACEUT ... | PYOTT DAVID E I | Director | Option Exercise | A | 72.01 | 9,000 | 648,090 | 9,000 | |
Jul 02 2019 | ALNY | ALNYLAM PHARMACEUT ... | PAUL STEVEN M | Director | Option Exercise | A | 72.01 | 9,000 | 648,090 | 9,000 |